Sales Revenue of Antiviral Therapies to Soar in the Near Future Owing to Growing Consumer Adoption

According to antiviral therapies market analysis by Research Dive, the global market forecast will surpass $66,016.5 million in 2027, growing at a 3.1% CAGR from $51,913.1 million in the year2019.

Antiviral Therapies Market, COVID-19 Impact:

The global antiviral therapies market has responded positively to the pandemic owing to rise in the utilization of antiviral drugs in the development of effective medicines for the COVID-19 treatment. In addition, leading players in the global marketplace are adopting strategies such as collaborations and partnerships to strengthen their place in the global marketplace. For instance, in May 2020, Merck & Co., Inc. made a collaboration with Ridgeback Biotherapeutics LP, a biotechnology company, to develop EIDD-2801, which is an oral antiviral candidate for treatment of COVID-19 patents. Through this collaboration, both companies aimed to develop innovative, safe and effective vaccines againstSARS-CoV-2 through antiviral therapies. This factor is predicted to fuel the growth of the market in the pandemic time.

How COVID-19 Impact on Antiviral Therapies Market. Click Here to Speak our expert Analyst@ https://www.researchdive.com/connect-to-analyst/78

Antiviral Therapies Market, Overview:

The significant factor for the antiviral therapies market growth includes increasing usage of antiviral in HIV diagnosis and hepatitis C treatment. As per Centers of Disease Control and Prevention (CDC), more than 38.0 million people were living with HIV in 2019 and about 52% of the people are were diagnosed with HIV in the U.S. Globally, around 53% of children and 68% of adults were living with HIV/AIDS requiring continuous antiretroviral therapy. Antiretroviral and antiviral therapies have been proven to be an effective way to diagnose HIV/AIDS. This aspect is predicted to fuel the market growth in the estimated time. Further, there has been adoption of new technologies such as nanotechnology in the manufacturing of antivirals to produce improved drugs that are capable of functioning against emerging viral diseases. This aspect is anticipated to create ample growth opportunities for the market in the upcoming years. However, high cost of the treatment and drug price are major limiting factors for the antiviral therapies market growth in the forecast timeframe.

Antiviral Therapies Market, Segmentation Analysis:

The herpes antiviral drug type is expected to rise at a faster rate and is predicted to reach a revenue up to $5,480.7 million by 2027. Increasing cases of herpes among population in the world is estimated to be the main boosting factor for the market growth in the prediction period. According to National Institutes of Drugs, in the U.S. about 90% of people are affected by herpes by the age of 50. This aspect is predicted to impel the demand for herpes antiviral drugs and is estimated to fuel the market growth in the forecast timeframe.

The online pharmacy distribution channel is expected to be a lucrative sub-segment in the coming years and is estimated to rise at a healthy CAGR of 5.0% during the review period. Due to lower prices medicines online, people are interested to buy from online retailers, which is estimated to be a major driver for the sub-segment growth in the forecast time. Online pharmacies offer lower pricing than conventional stores, with lower transaction & product costs, efficient delivery and simple ordering process. This aspect is predicted to propel the growth of the market in the analysis period.

Antiviral Therapies Market, Regional Insights:

The market in Asia-Pacific will witness growth at a faster rate of 4.1% CAGR and is estimated to generate significant investment opportunities for the market players in the forecast time. According to WHO, western pacific region has a high incidence of hepatitis B & C with high prevalence rate of liver cancer in the several countries such as India, China, South Korea and Vietnam. This is majorly due to excessive alcohol consumption, mother to child transmission and other reasons. This factor is predicted to fuel the demand for antiviral drugs in the forecast region.

Get | Download an Exclusive Sample Rpeort@ https://www.researchdive.com/download-sample/78

Download the sample report to delve into the North America, Europe and LAMEA share in the global antiviral therapies market.

Antiviral Therapies Market, Significant Market Players:

GlaxoSmithKline plc
Gilead Sciences, Inc.
F. Hoffmann-La Roche Ltd
Bristol-Myers Squibb Company
Abbott
Johnson & Johnson Services, Inc.
AstraZeneca
AbbVie Inc.
Aurobindo Pharma
Merck & Co., Inc.

Covaxin vs Covishield: A Comparison between the Covid-19 Vaccines of India

The second wave of Covid-19 pandemic has reminded people the hard times faced during the coronavirus outbreak in 2020 in India. However, there is still an upper hand in 2021 in the fight against Covid-19, and this can be attributed to the nationwide vaccination drive. It has been clear that getting vaccinated is one of the simple yet effective ways to combat the pandemic. Vaccination helps in producing antibodies and boosts the immune system to fight against any infection. Besides, getting Covid-19 vaccination is known to reduce the severity of the infection and helps in lowering the chances of getting hospitalized due to the severe infection caused due to Covid-19. Covaxin Vs Covishield Currently, the Indian Government has approved two vaccines namely Covaxin and Covishield to fight Covid-19. Many people are wondering which vaccine is better among the two, and here is a quick read to help them answer all their queries. Covaxin Covaxin was given approval for by the Indian

Contactless Payment Market size share growth analysis market demand

Contactless payment, also called as a tap-and-go system is a secure mode where the transactions are done using technologies such as NFC (near field communication), RFID (radio frequency identification), infrared, and bluetooth. Contactless payment is hassle-free and convenient for customers as it takes only one-tenth of the time taken by the old-style electronic transaction.Contactless payment is becoming popular owing to its benefits such as secure and fast payments without any need for cash or identifying details. Initially, these type of payments or cards were used for the purpose oftravelling tickets only. But today, this technology has evolved and is helping customers to make payments for almost anything. However, the permissible amount for a contactless payment varies by country and by the bank. Access to PDF Sample Report Here! @ https://www.researchdive.com/download-sample/181 Recent Developments in the Contactless Payment Industry As per a Research Dive blog, the digital e

Development: Aerospace 3D Printing Market Strategy Planning by Top Manufacturers

Aerospace 3D Printing Market Analysis 2026: According to a study of the Research Dive, aerospace 3D printing market forecast shall cross $5,933.4 million by 2026 , growing at a CAGR of 26.8% during forecast period. Aerospace 3D printing is primarily used to increase the efficiency of A&D supply chain, reduction of storage costs of inventory and waste production materials. Furthermore, the Aerospace 3D printing industry is focusing more on creating parts of aircraft that are lighter and stronger than parts made by using traditional manufacturing. Astonishing advantages of 3D printings in the supply chain of the aerospace and defense industry are projected to surge in the global market. In addition, the financial support provided by the government and non-government organizations across the globe is also driving the 3D printing in aerospace industry. For instance, National Aerospace Technology Exploitation Programme grants £140,000 funds for UK based company Sigma Components

Industrial Research World

Search This Blog